An electrochemiluminescence (ECL, no manufacturer details)-based study, using a case–control group of 74 PD patients and 60 healthy control subjects, demonstrated that the total α-synuclein levels turned out to unaltered (11.93 pg/mL vs. 12.23 pg/mL) [37]. This evidence concerns the gene SNCA and Parkinson disease.